Nippon India Pharma Fund vs Aditya Birla Sun Life Pharma and Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
Chart Comparison
Overview
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹8265 Cr | ₹854 Cr |
| Min Investment | ₹5000 | ₹1000 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 05 Jun 2004 | 10 Jul 2019 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | 21% | 31% |
| Expense Ratio | 1.82 | 2.27 |
| Manager | Sailesh Raj Bhan | Dhaval Joshi |
| ISIN Code | INF204K01968 | INF209KB1N91 |
| Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 1 Month | 0.36% | 1.28% |
| 6 Month | -1.78% | 0.29% |
| 1 Year | -2.15% | -2.03% |
| 3 Year | 21.66% | 21.51% |
| 5 Year | 14.26% | 12.75% |
SIP Return Analysis
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 6 Month | -0.18% | -0.28% |
| 1 Year | 4.56% | 5.71% |
| 3 Year | 14.72% | 14.84% |
| 5 Year | 15.38% | 14.81% |
Rolling Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 1 Year | 16.54% | 21.3% |
| 3 Year | 20.99% | 17.29% |
| 5 Year | 20.35% | 19.88% |
Risk Management
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Standard Deviation | 14.36% | 14.83% |
| Sharp | 1.01% | 0.95% |
| Beta | 0.87% | 0.93% |
| Alpha | 1.33% | 0.2% |
Fund Managers
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Name | Sailesh Raj Bhan | Dhaval Joshi |
| Total AUM | ₹96086 Cr | ₹361932 Cr |
| Funds Managed | 5 | 55 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Market Cap
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Others | 3.47 | 2.33 |
| Mid Cap | 34.55 | 40.96 |
| Small Cap | 29.97 | 29.58 |
| Large Cap | 32.01 | 27.13 |
Sector Allocation
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Others | 2.63 | 2.33 |
| Healthcare | 97.37 | 96.8 |
| Basic Materials | - | 0.87 |
Top Comparisons
Motilal Oswal Multi Asset Fund - Regular Plan - Growth Option
3Y Returns5.18%
Edelweiss Multi Asset Allocation Fund - Reg (G)
3Y Returns0%
Mirae Asset Corporate Bond Fund Regular Growth
3Y Returns7.13%
UTI Corporate Bond Fund - Regular Plan - Growth Option
3Y Returns7.44%
HDFC Banking and Financial Services Fund - Growth Option
3Y Returns15.77%
Nippon India Nifty Bank Index Fund - Reg (G)
3Y Returns0%
Nippon India Large Cap Fund- Growth Plan Bonus Option
3Y Returns%
Tata Large Cap Fund -Regular Plan - Growth Option
3Y Returns14.47%